Among patients of similar ages, a low serum anti-mullerian hormone(AMH) does not predict a higher incidence of aneuploidy in embryos tested with comprehensive chromosomal screening (CCS)

Abstract

Serum AMH levels have been studied as predictors of ovarian response to exogenous gonadotropins as well as pregnancy rates among patients undergoing IVF. The purpose of this study was to determine whether low serum AMH levels prognosticate the aneuploidy rate in embryos, further defining its role as a marker of oocyte quantity and/or quality.